ID   MDV OU2.2
AC   CVCL_Y590
SY   MDVOU2.2; OU2.2
DR   ATCC; CRL-11985
DR   Wikidata; Q54904878
RX   Patent=US5866117;
RX   PubMed=8553556;
RX   PubMed=9126245;
CC   Group: Bird cell line.
CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Discontinued: ATCC; CRL-11985; probable.
OX   NCBI_TaxID=9031; ! Gallus gallus
AG   Embryo
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 25-02-19; Version: 7
RX   Patent=US5866117;
RA   Coussens P.M., Abujoub A.A.;
RT   "Sustainable chick cell line infected with Marek's disease virus.";
RL   Patent number US5866117, 02-Feb-1999.
RX   PubMed=8553556; DOI=10.1006/viro.1995.0065;
RA   Abujoub A.A., Coussens P.M.;
RT   "Development of a sustainable chick cell line infected with Marek's
RT   disease virus.";
RL   Virology 214:541-549(1995).
RX   PubMed=9126245; DOI=10.1006/viro.1997.8444;
RA   Abujoub A.A., Coussens P.M.;
RT   "Evidence that Marek's disease virus exists in a latent state in a
RT   sustainable fibroblast cell line.";
RL   Virology 229:309-321(1997).